The Multiple Myeloma Research Foundation (MMRF) will launch the eighth installment of its annual endurance cycling program, Road to Victories, on August 24. The event, which will take place in California's Wine Country, aims to raise funds and awareness for multiple myeloma research.
Since its inception in 2017, the Road to Victories program has raised over $2 million, every dollar of which directly supports MMRF's efforts to accelerate a cure for myeloma. The program has seen the participation of 160 individuals, including 31 myeloma patients, as well as caregivers, healthcare professionals, family members, and Johnson & Johnson employees.
The event is sponsored by Johnson & Johnson, a longstanding partner of MMRF. "At Johnson & Johnson, we believe in a future where multiple myeloma is no longer a life-threatening disease, but a curable condition," said Tyrone Brewer, President, U.S. Hematology at Johnson & Johnson Innovative Medicine. He emphasized the shared commitment between Johnson & Johnson and MMRF to advance treatments and redefine possibilities for multiple myeloma patients.
This year's Road to Victories will see participants cycling through Napa Valley and Sonoma vineyards over six days, starting from San Francisco. The event draws riders from various parts of the country, including Chicago, San Francisco, Sacramento, Denver, Washington DC, Cleveland, Columbus, and Pennsylvania.
Michael Andreini, President and CEO of MMRF, expressed gratitude towards the dedicated cyclists and Johnson & Johnson for their support. "We are inspired by their determination to help us defeat myeloma. This program helps us fund critical research, raise awareness, and empower patients," he said.
Since its founding, MMRF has committed over $600 million to research, directed nearly 90% of funds to research and related programs, helped bring over 15 FDA-approved therapies to market, and opened nearly 100 clinical trials. The foundation's efforts have significantly improved the life expectancy of myeloma patients.
MMRF's initiatives, such as the Road to Victories program, are crucial in advancing the development and delivery of next-generation therapies. These efforts leverage data to identify optimal and personalized treatment approaches, ultimately aiming to make myeloma a curable condition.
For more information about the event and to learn about the cyclists' bios and ride schedules, visit the Road to Victories website. Further details about MMRF's mission and initiatives can be found on their official website.
